Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Sensors (Basel) ; 19(20)2019 Oct 16.
Article in English | MEDLINE | ID: mdl-31623113

ABSTRACT

With the popularization of the Internet-of-Things, various applications have emerged to make life easier. These applications generate a large amount of user data. Analyzing the data obtained from these applications, one can infer personal information about each user. Considering this, it is clear that ensuring privacy in this type of application is essential. To guarantee privacy various solutions exist, one of them is UbiPri middleware. This paper presents a decentralized implementation of UbiPri middleware using the Ethereum blockchain. Smart contracts were used in conjunction with a communication gateway and a distributed storage service to ensure users privacy. The results obtained show that the implementation of this work ensures privacy at different levels, data storage security, and performance regarding scalability in the Internet of Things environments.

2.
Sensors (Basel) ; 18(5)2018 May 08.
Article in English | MEDLINE | ID: mdl-29738472

ABSTRACT

New solutions for managing waste have emerged due to the rise of Smart Cities and the Internet of Things. These solutions can also be applied in rural environments, but they require the deployment of a low cost and low consumption sensor network which can be used by different applications. Wireless technologies such as LoRa and low consumption microcontrollers, such as the SAM L21 family make the implementation and deployment of this kind of sensor network possible. This paper introduces a waste monitoring and management platform used in rural environments. A prototype of a low consumption wireless node is developed to obtain measurements of the weight, filling volume and temperature of a waste container. This monitoring allows the progressive filling data of every town container to be gathered and analysed as well as creating alerts in case of incidence. The platform features a module for optimising waste collection routes. This module dynamically generates routes from data obtained through the deployed nodes to save energy, time and consequently, costs. It also features a mobile application for the collection fleet which guides every driver through the best route—previously calculated for each journey. This paper presents a case study performed in the region of Salamanca to evaluate the efficiency and the viability of the system’s implementation. Data used for this case study come from open data sources, the report of the Castilla y León waste management plan and data from public tender procedures in the region of Salamanca. The results of the case study show a developed node with a great lifetime of operation, a large coverage with small deployment of antennas in the region, and a route optimization system which uses weight and volume measured by the node, and provides savings in cost, time and workforce compared to a static collection route approach.

3.
J Integr Bioinform ; 12(4): 278, 2015 Oct 21.
Article in English | MEDLINE | ID: mdl-26673929

ABSTRACT

Triple negative breast cancer is an aggressive form of breast cancer. Despite treatment with chemotherapy, relapses are frequent and response to these treatments is not the same in younger women as in older women. Therefore, the identification of genes that cause this difference is required. The identification of therapeutic targets is one of the sought after goals to develop new drugs. Within the range of different hybridization techniques, the developed system uses expression array analysis to measure the expression of the signal levels of thousands of genes in a given sample. Probesets of Gene 1.0 ST GeneChip arrays provide categorical genome transcript coverage, providing a measurement of the expression level of the sample. This paper proposes a multi-agent system to manage information of expression arrays, with the goal of providing an intuitive system that is also extensible to analyze and interpret the results. The roles of agent integrate different types of techniques, statistical and data mining methods that select a set of genes, searching techniques that find pathways in which such genes participate, and an information extraction procedure that applies a CBR system to check if these genes are involved in the disease.


Subject(s)
Breast Neoplasms , Gene Expression Profiling/methods , Gene Expression Regulation, Neoplastic , Genes, Neoplasm , Oligonucleotide Array Sequence Analysis/methods , Adult , Aged , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Female , Humans , Middle Aged
4.
BMC Cancer ; 15: 238, 2015 Apr 08.
Article in English | MEDLINE | ID: mdl-25880332

ABSTRACT

BACKGROUND: MicroRNAs are known to inhibit gene expression by binding to the 3'UTR of the target transcript. Downregulation of miR-223 has been recently reported to have prognostic significance in CLL. However, there is no evidence of the pathogenetic mechanism of this miRNA in CLL patients. METHODS: By applying next-generation sequencing techniques we have detected a common polymorphism (rs2307842), in 24% of CLL patients, which disrupts the binding site for miR-223 in HSP90B1 3'UTR. We investigated whether miR-223 directly targets HSP90B1 through luciferase assays and ectopic expression of miR-223. Quantitative real-time polymerase chain reaction and western blot were used to determine HSP90B1 expression in CLL patients. The relationship between rs2307842 status, HSP90B1 expression and clinico-biological data were assessed. RESULTS: HSP90B1 is a direct target for miR-223 by interaction with the putative miR-223 binding site. The analysis in paired samples (CD19+ fraction cell and non-CD19+ fraction cell) showed that the presence of rs2307842 and IGHV unmutated genes determined HSP90B1 overexpression in B lymphocytes from CLL patients. These results were confirmed at the protein level by western blot. Of note, HSP90B1 overexpression was independently predictive of shorter time to the first therapy in CLL patients. By contrast, the presence of rs2307842 was not related to the outcome. CONCLUSIONS: HSP90B1 is a direct target gene of miR-223. Our results provide a plausible explanation of why CLL patients harboring miR-223 downregulation are associated with a poor outcome, pointing out HSP90B1 as a new pathogenic mechanism in CLL and a promising therapeutic target.


Subject(s)
High-Throughput Nucleotide Sequencing/methods , Leukemia, Lymphocytic, Chronic, B-Cell/genetics , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Membrane Glycoproteins/genetics , MicroRNAs/genetics , Sequence Analysis, DNA/methods , 3' Untranslated Regions , Adult , Aged , Aged, 80 and over , Binding Sites , Cell Line, Tumor , Female , Gene Expression Regulation, Neoplastic , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/metabolism , Male , Membrane Glycoproteins/metabolism , MicroRNAs/chemistry , MicroRNAs/metabolism , Middle Aged , Polymorphism, Single Nucleotide , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL
...